Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS [Parenthetical]

v2.4.0.8
CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)
Dec. 31, 2013
Dec. 31, 2012
Research And Development Contract Liabilities To Related Parties $ 34,398 $ 9,679
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 41,583,097 41,583,097
Common stock, shares outstanding 41,583,097 41,583,097